Richards Robert J
Robert J Richards, Department of Gastroenterology and Hepatology, Stony Brook University, Stony Brook, NY 11793-8173, United States.
World J Gastrointest Endosc. 2011 Nov 16;3(11):209-12. doi: 10.4253/wjge.v3.i11.209.
Patients with Crohn's disease may develop an abdominal or pelvic abscess during the course of their illness. This process results from transmural inflammation and penetration of the bowel wall, which in turn leads to a contained perforation and subsequent abscess formation. Management of patients with Crohn's related intra-abdominal and pelvic abscesses is challenging and requires the expertise of multiple specialties working in concert. Treatment usually consists of percutaneous abscess drainage (PAD) under guidance of computed tomography in addition to antibiotics. PAD allows for drainage of infection and avoidance of a two-stage surgical procedure in most cases. It is unclear if PAD can be considered a definitive treatment without the need for future surgery. The use of immune suppressive agents such as anti-tumor necrosis factor-α in this setting may be hazardous and their appropriate use is controversial. This article discusses the management of spontaneous abdominal and pelvic abscesses in Crohn's disease.
克罗恩病患者在病程中可能会出现腹部或盆腔脓肿。这一过程是由透壁性炎症和肠壁穿透引起的,进而导致局限性穿孔和随后的脓肿形成。克罗恩病相关的腹腔内和盆腔脓肿患者的管理具有挑战性,需要多个专科协同工作的专业知识。治疗通常包括在计算机断层扫描引导下进行经皮脓肿引流(PAD)以及使用抗生素。PAD在大多数情况下能够排出感染物并避免进行两阶段手术。目前尚不清楚PAD是否可被视为无需后续手术的确定性治疗方法。在这种情况下使用免疫抑制剂如抗肿瘤坏死因子-α可能具有危险性,其合理使用存在争议。本文讨论了克罗恩病自发性腹部和盆腔脓肿的管理。